Home > Insider Trading > Filing (0001144204-16-120030)

Filing Details

Accession Number:: 0001144204-16-120030
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-17 17:10:12
Reporting Period:: 2016-08-15

Filing Date:: 2016-08-17
Accepted Time:: 2016-08-17 17:10:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1607962	Rewalk Robotics Ltd.	RWLK	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
923792	J Winston Churchill	7 Great Valley Parkway, Suite 109 Malvern PA 19355-1446	No	No	Yes	No
1235402	Abraham Ludomirski	7 Great Valley Parkway, Suite 109 Malvern PA 19355-1446	No	No	Yes	No
1602484	Scp Vitalife Partners (Israel) Ii, L.p.	7 Great Valley Parkway, Suite 190 Malvern PA 19355-1446	No	No	Yes	No
1662464	Scp Vitalife Ii Associates, L.p.	7 Great Valley Parkway, Suite 109 Malvern PA 19355-1446	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares, Par Value Nis 0.01 Per Share	Disposition	2016-08-15	10,958	$6.45	375,762	No	4	S	Direct
Ordinary Shares, Par Value Nis 0.01 Per Share	Disposition	2016-08-16	1,561	$6.42	374,201	No	4	S	Direct
Ordinary Shares, Par Value Nis 0.01 Per Share	Disposition	2016-08-16	12,519	$6.29	361,682	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.4000 to $6.5350, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
The Ordinary Shares are directly held by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife") and indirectly held by SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"), the sole general partner of SCP Vitalife, SCP Vitalife II, GP, Ltd. ("SCP Vitalife GP"), the sole general partner of SCP Vitalife Associates, and the individual directors of SCP Vitalife GP (SCP Vitalife Associates, SCP Vitalife GP and the individual directors of SCP Vitalife GP together, the "SCP Vitalife Indirect Reporting Persons"). The individual directors of SCP Vitalife GP are Jeffrey Dykan, Winston J. Churchill, Abraham Ludomirski and Wayne B. Weisman. The SCP Vitalife Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the SCP Vitalife Ordinary Shares in which the SCP Vitalife Indirect Reporting Persons have no pecuniary interest.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.4000 to $6.4700, inclusive. The reporting person undertakes to provide to ReWalk, any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2100 to $6.4500, inclusive. The reporting person undertakes to provide to ReWalk, any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.